Onconetix, Inc. (ONCO)
1.20
+0.03
(+2.56%)
USD |
NASDAQ |
May 29, 16:00
1.22
+0.02
(+1.67%)
After-Hours: 20:00
Onconetix EPS Diluted (Quarterly) : -67.06 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -0.4303 |
| Sensei Biotherapeutics, Inc. | -3.622 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.215M |
| Revenue (Quarterly) | 0.0215M |
| Total Expenses (Quarterly) | 4.236M |
| Enterprise Value | -2.049M |
| Gross Profit Margin (Quarterly) | -7.91% |
| Profit Margin (Quarterly) | -19.60K% |
| Earnings Yield | -36.31K% |
| Normalized Earnings Yield | -36936.06 |